Vaccines were among the biggest medical breakthroughs of the 20th century. In the past
2 years, more than 15 new gene and immunotherapy medicines have come to market and at least 25 products are in late stage clinical trials.
Theta' s report covers trends and advancements in global vaccines markets that have occurred in 2001 and 2002. This study spotlights emerging
therapeutic vaccine markets and focuses on novel therapeutics based on gene therapy, immunoproteins, and antibodies.
Key issues discussed in this report:
1. Markets and advancements in:
- preventative pediatric vaccines
- adult at-risk vaccines
- therapeutic vaccines (including those based on antibodies, immunoproteins, DNA epitopes)
2. Delivery systems engineered to target diseased cells
3. Review of the progress in disease vaccine development for:
- cancer
- autoimmune disease
- cardiovascular disease
- gastrointestinal disorders
- sexually transmitted diseases
- infectious diseases
4. Profiles of the top vaccine companies, with mini-profiles of selected innovators
View Cart
